|Agnaldo J Lopes, PhD|
18 Years - 60 Years
Patients with sickle cell anemia, of both sexes, aged ≥ 18 years.
Patients who have clinical stability and are eligible for the treatment protocol.
Presence of comorbidities not related to sickle cell anemia.
Patients with inability to perform the six-minute walk test.
Patients who have cognitive impairment that impairs their inclusion in the study.
Abandonment of treatment during the application of the protocol.
Uncontrolled hypertension or use of psychotropic drugs.
Any significant limitations due to osteoarthropathy.
Have had any orthopedic surgery in the previous year.